A review of activity indices and end points for clinical trials in children with Crohn's disease (Q36022836)

11 August 2017

1 reference

title

A review of activity indices and end points for clinical trials in children with Crohn's disease (English)

1 reference

11 August 2017

0 references

7

Brian G Feagan

1 reference

11 August 2017

1

Anne M Griffiths

1 reference

11 August 2017

Anthony R Otley

2

1 reference

ORCID Public Data File 2021

Jeffrey S Hyams

series ordinal

3

object named as

Jeffrey Hyams

1 reference

11 August 2017

5

Richard J Grand

1 reference

11 August 2017

6

Athos Bousvaros

1 reference

11 August 2017

Antonio R Quiros

4

1 reference

PubMed ID

15677913

11 August 2017

George R Ferry

series ordinal

8

1 reference

11 August 2017

1 February 2005

1 reference

Inflammatory Bowel Diseases

11 August 2017

1 reference

11 August 2017

11

1 reference

11 August 2017

2

1 reference

11 August 2017

185-196

1 reference

Presenting features of inflammatory bowel disease in Great Britain and Ireland

11 August 2017

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Growth and clinical course of children with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Treatment of inflammatory bowel disease in childhood: best available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Clinical longitudinal standards for height and height velocity for North American children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

The relationship between stature, growth, and short-term changes in height and weight in normal prepubertal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Evaluation of growth rate in height over periods of less than one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Periodical changes of short term growth velocity ('mini growth spurts') in human growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

The IMPACT Questionnaire: A Valid Measure of Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Quality of life in inflammatory bowel disease: a cross-cultural comparison of English and Canadian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Measuring quality of life in children with inflammatory bowel disease: the impact-II (NL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

Knemometry, Urine Cortisol Excretion, and Measures of the Insulin-Like Growth Factor Axis and Collagen Turnover in Children Treated with Inhaled Glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00013

10.1097/00054725-200502000-00013

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15677913